new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Xenoport Inc
Xenoport Inc_20100107
Xenoport Inc_20100121
  

Xenoport Inc patents

Recent patent applications related to Xenoport Inc. Xenoport Inc is listed as an Agent/Assignee. Note: Xenoport Inc may have other listings under different names/spellings. We're not affiliated with Xenoport Inc, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "X" | Xenoport Inc-related inventors




Date Xenoport Inc patents (updated weekly) - BOOKMARK this page
03/16/17Gaba analog prodrug sustained release oral dosage forms
02/16/17Crystalline forms of (n,n-diethylcarbamoyl)methyl methyl (2e)but-2-ene-1,4-dioate, methods of synthesis and use
02/09/17Oral dosage forms having a high loading of a gabapentin prodrug
06/23/16Methods of synthesizing a levodopa ester prodrug
04/28/16Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
03/31/16Prodrugs of gaba analogs, compositions and uses thereof
12/10/15Crystalline form of y-aminobutyric acid analog
11/05/15Anhydrous and hemihydrate crystalline forms of an (r)-baclofen prodrug, methods of synthesis and methods of use
10/29/15Prodrugs of gaba analogs, compositions and uses thereof
10/29/15Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects
09/24/15Pharmaceutical compositions of fumaric acid esters
09/10/15Treatment of multiple sclerosis and psoriasis using prodrugs of methyl hydrogen fumarate
07/16/15Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof
07/09/15Methods of administering monomethyl fumarate
06/11/15Cocrystals of (n,n-diethylcarbamoyl)methyl methyl (2e)but-2-ene-1,4-dioate
06/11/15Method of making 1-(acyloxy)-alkyl carbamate compounds
03/19/15Nanoparticle compositions of dimethyl fumarate
03/12/15Gaba analog prodrug sustained release oral dosage forms
03/12/15Crystalline forms of (n,n-diethylcarbamoyl)methyl methyl (2e)but-2-ene-1,4-dioate, methods of synthesis and use
02/05/15Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects
12/25/14Cocrystals of dimethyl fumarate
11/27/14Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
11/27/14Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
11/27/14Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects
09/25/14Pharmaceutical compositions of dimethyl fumarate
09/18/14Methods of administering monomethyl fumarate
08/28/14Method of making 1-(acyloxy)-alkyl carbamate compounds
08/21/14Crystalline form of y-aminobutyric acid analog
06/26/14Cocrystals of (n,n-diethylcarbamoyl)methyl methyl (2e)but-2-ene-1,4-dioate
03/06/14Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
03/06/14Anhydrous and hemihydrate crystalline forms of an (r)-baclofen prodrug, methods of synthesis and methods of use
02/27/14Oral dosage forms having a high loading of a methyl hydrogen fumarate prodrug
02/27/14Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
02/27/14Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects
02/27/14Methods of use for monomethyl fumarate and prodrugs thereof
02/20/14Morpholinoalkyl fumarate compounds, pharmaceutical compositions, and methods of use
08/08/13Morpholinoalkyl fumarate compounds, pharmaceutical compositions, and methods of use
07/18/13Levodopa prodrug mesylate hydrate
05/23/13Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
04/25/13Prodrugs of gaba analogs, compositions and uses thereof
02/14/13Anhydrous and hemihydrate crystalline forms of an (r)-baclofen prodrug, methods of synthesis and methods of use
11/22/12Levodopa prodrugs, and compositions and uses thereof
07/26/12Levodopa prodrugs, and compositions and uses thereof
06/21/12Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
04/19/12Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof
04/05/122'-c-methyl-ribofuranosyl cytidine prodrugs, pharmaceutical compositions, and uses thereof
02/16/12Use of prodrugs of gaba analogs for treating diseases
02/09/12Gamma-amino-butyric acid derivatives as gabab receptor ligands
02/09/12Methods of using prodrugs of pregabalin
01/19/12Methods of treating fragile x syndrome, down's syndrome, autism and related disorders
01/12/12Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
12/22/11Crystalline form of y-aminobutyric acid analog
12/01/11Method of treatment of fragile x syndrome, down's syndrome, autism and related disorders
09/15/11Crystalline form of a (3s)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use
09/01/11Use of (3r)-4--3-(4-chlorophenyl) butanoic acid for treating urinary incontinence
08/18/11Levodopa prodrugs, and compositions and uses thereof
07/28/11Oral dosage forms having a high loading of a tranexamic acid prodrug
06/02/11Prodrugs of gamma-amino acid, alpha-2-delta ligands, pharmaceutical compositions and uses thereof
05/26/11Prodrugs of alpha-2-delta ligands, pharmaceutical compositions and uses thereof
05/12/11Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use
03/10/11Uses of acyloxyalkyl carbamate prodrugs of tranexamic acid
02/03/11Catechol protected levodopa diester prodrugs, compositions, and methods of use
01/27/11Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
01/27/11Crystalline form of y-aminobutyric acid analog
01/13/11Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use
Patent Packs
10/21/10Gamma-amino-butyric acid derivatives as gabab receptor ligands
10/21/10Prodrugs of gaba analogs, compositions and uses thereof
10/07/10Sustained release oral dosage forms of an r-baclofen prodrug
09/09/10Oral dosage forms having a high loading of a gabapentin prodrug
08/05/10Levodopa prodrugs, and compositions and uses thereof
07/08/10Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use
07/01/10Treating and/or preventing urinary incontinence using prodrugs of gaba analogs
06/03/10Creatine phosphate analog prodrugs, compositions and uses thereof
06/03/10Sustained release particulate oral dosage forms of (r)-baclofen and methods of treatment
04/22/10Levodopa prodrug mesylate hydrate
04/22/10Methods of synthesizing a levodopa ester prodrug
04/08/10Amino acid derived prodrugs of propofol, compositions, uses and crystalline forms thereof
03/04/10Crystalline form of y-aminobutyric acid analog
02/25/10Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
02/18/10Methods for synthesis of acyloxyalkyl compounds
Patent Packs
02/11/10Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use
01/21/10Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
01/07/10Levodopa prodrugs, and compositions and uses thereof
12/31/09Levodopa prodrug mesylate, compositions thereof, and uses thereof
12/17/09Aromatic prodrugs of propofol, compositions and uses thereof
12/10/09Methods of screening agents, conjugates or conjugate moieties for transport by a pept2 transporter
11/19/09Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
11/19/09Amino acid derived prodrugs of propofol, compositions and uses thereof
11/12/09Epitope-captured antibody display
10/29/09Cyclic 1-(acyloxy)-alkyl prodrugs of gaba analogs, compositions and uses thereof
09/24/09Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
09/17/09Compounds displayed on replicable genetic packages and methods of using same
09/03/09Substrates and screening methods for transport proteins
08/27/09Crystalline form of a (3s)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use
08/27/09Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
08/20/09Mct1 transporters expressed in blood brain barrier cells
08/06/09Sustained release particulate oral dosage forms of (r) baclofen and methods of treatment
07/30/09Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
07/30/09Acyloxyalkyl carbamate prodrugs of alpha-amino acids, methods of synthesis and use
07/30/09Enantiomerically resolving acyloxyalkyl thiocarbonates used in synthesizing acyloxyalkyl carbamate prodrugs
06/18/09Levodopa prodrug mesylate, compositions thereof, and uses thereof
06/11/09Lat1 transporters expressed in blood brain barrier cells
05/28/09Levodopa prodrugs, and compositions and uses thereof
05/14/09Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use
05/07/09Use of prodrugs of gaba b agonists for treating neuropathic and musculoskeletal pain
04/16/09Internally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
03/19/09Use of propofol prodrugs for treating neuropathic pain
01/21/10Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
01/07/10Levodopa prodrugs, and compositions and uses thereof







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Xenoport Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Xenoport Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';